How neurotensin affects dopamine neurons and behavior related to drug use
Differential modulation of dopamine neurons by distinct neurotensin inputs
This study is looking at how a brain chemical called neurotensin affects dopamine, which is important for understanding why people might crave drugs or engage in addictive behaviors, and it could help find new ways to treat addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11077783 on NIH RePORTER |
What this research studies
This research investigates the role of neurotensin (NTS) in modulating dopamine neurons, which are crucial for understanding behaviors related to addiction and drug reinforcement. By examining how NTS interacts with dopamine neurons in the brain, particularly in the ventral tegmental area, the study aims to uncover the physiological mechanisms behind motivated behaviors and responses to drugs of abuse. The researchers will use advanced mapping techniques to identify brain regions that influence NTS signaling and explore how these interactions affect dopamine release and behavior. This could provide insights into the biological underpinnings of addiction and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who have a history of substance use or addiction.
Not a fit: Patients who do not have a history of substance use or are under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for addiction by targeting the neurobiological mechanisms involved in drug reinforcement.
How similar studies have performed: Previous research has shown promising results in understanding the role of neurotensin in addiction, suggesting that this approach could yield valuable insights.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Soden, Marta E — University of Washington
- Study coordinator: Soden, Marta E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.